Gabriela Reyes

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

GRIN2D-Related Developmental and Epileptic Encephalopathy Associated With Polymorphic Seizures Including Epileptic Spasms.

GRIN2D-Related Developmental and Epileptic Encephalopathy Associated With Polymorphic Seizures Including Epileptic Spasms.

Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Published: November 10, 2025

Epileptic spasms in clusters without hypsarrhythmia in infancy and childhood: A single age-dependent type of epilepsy or well-defined epileptic syndrome?

Epileptic spasms in clusters without hypsarrhythmia in infancy and childhood: A single age-dependent type of epilepsy or well-defined epileptic syndrome?

Journal: Epilepsy research

Published: January 18, 2024

Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients.

Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients.

Journal: Epilepsy & behavior : E&B

Published: August 25, 2023

Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood.

Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood.

Journal: Epilepsy & behavior : E&B

Published: January 13, 2023

Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients.

Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients.

Journal: Medicina

Published: December 26, 2022

Telemedicine- versus outpatient-based initiation and management of ketogenic diet therapy in children with drug-resistant epilepsy during the COVID-19 pandemic.

Telemedicine- versus outpatient-based initiation and management of ketogenic diet therapy in children with drug-resistant epilepsy during the COVID-19 pandemic.

Journal: Seizure

Published: February 24, 2022

Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy.

Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy.

Journal: Seizure

Published: November 25, 2021

Status of epileptic spasms: A study of 21 children.

Status of epileptic spasms: A study of 21 children.

Journal: Epilepsy & behavior : E&B

Published: September 07, 2021

Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy.

Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy.

Journal: Epilepsia

Published: September 22, 2020

Corrigendum to "Effectiveness of cannabidiol in a prospective cohort of children with drug resistant epileptic encephalopathy in Argentina" [Seizure 80 (2020) 75-80].

Corrigendum to "Effectiveness of cannabidiol in a prospective cohort of children with drug resistant epileptic encephalopathy in Argentina" [Seizure 80 (2020) 75-80].

Journal: Seizure

Published: July 14, 2020

Molecular diagnosis of epileptic encephalopathy of the first year of life applying a customized gene panel in a group of Argentinean patients.

Molecular diagnosis of epileptic encephalopathy of the first year of life applying a customized gene panel in a group of Argentinean patients.

Journal: Epilepsy & behavior : E&B

Published: June 02, 2020

Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.

Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.

Journal: Epilepsy & behavior : E&B

Published: February 27, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026